Located in Milwaukee, Wisconsin, the Versiti Blood Research Institute (VBRI) is the largest blood-focused research institute in the United States. With over 30 basic, translational, and clinical researchers, the institute is dedicated to advancing scientific knowledge and developing innovative therapies related to blood and blood disorders. The institute's research interests encompass a wide range of topics, including transfusion medicine, cellular therapy, thrombosis/hemostasis, immunology, and hematologic malignancies. As a vital part of Versiti, a non-profit organization with a blood bank at its core, the VBRI strives to improve lives through innovative research and the development of novel diagnostics and treatments.
VBRI is part of the Milwaukee Regional Medical Campus, a rapidly growing clinical-translational research hub. VBRI’s proximity to the Medical College of Wisconsin, Childrens’ Hospital of Wisconsin, and Froedtert Hospital facilitates seamless interdisciplinary collaborations. A range of exemplary core facilities support highly competitive research. In the summer of 2024, construction of a new research building will start, doubling existing VBRI research space to enable the recruitment of 10-15 new faculty. With its renowned researchers, strategic expansion plans and location in a highly collaborative environment, the VBRI is poised to maintain and expand its position as one of the leading hematology institutes in the world.
Under the direction of a Principal Investigator, further develops and expands understanding of scientific theory in his/her area of interest. Incumbent also learns and applies scientific laboratory techniques and gains experience in other areas of research that will lead to increased probability of success as an independent scientist. This is a training position with an expected duration of 1 – 3 years.
Chromatin dynamics and gene regulation in normal and malignant hematopoiesis
Acute myeloid leukemia (AML) and several hematological malignancies arise from acquisition of multiple stepwise genetic and epigenetic changes in hematopoietic stem and progenitor cells. Understanding the regulatory pathways that are deregulated in hematopoietic stem and progenitor cells is important to better understand the development of leukemia and to design novel therapeutic strategies for the treatment of leukemia. With that broad focus in mind, our lab applies genetic, epigenetic and biochemical approaches in genetically modified mouse models, humanized mouse models and human primary leukemic cells. Our research focuses on three areas:
1. Interplay between transcription factors and chromatin dynamics in normal and malignant hematopoietic stem cells (HSC)
2. Transcriptional deregulation in AML
3. Development and optimization of AML PDX models
Strong experience in molecular biology, stem cell biology, genomics, bioinformatics and/or cancer research is desirable. Successful candidates should be willing to work with mouse models.
Education
Experience
Knowledge, Skills and Abilities
Tools and Technology
#LI-EH1
#LI-Onsite
#VBRI